Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial's eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 301 - 320 of 510 trials
Titlesort icon Investigator Disease(s)
A Phase II Study of Cabozantinib in Patients with Advanced Non-Small Cell Lung Cancer
[Protocol 12-097]
Drilon, Alexander
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase II Study of BYL719 plus AMG 479 (Ganitumab) in Patients with Advanced Ovarian Cancer or Hormone Receptor-Positive Breast Cancer
[Protocol 13-251]
Modi, Shanu
  • Breast Cancer
  • Ovarian Cancer
A Phase II Study of Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post-Transplantation Donor Lymphocyte Infusions for Patients with Relapsed or High-Risk Multiple Myeloma
[Protocol 10-051]
Koehne, Guenther
  • Blood & Marrow Stem Cell Transplantation
    • Sibling and Unrelated Volunteer
  • Hematology
    • Multiple Myeloma
A Phase II Study of Bulk Versus Fractionated Stem Cell Infusions in Patients with Hematologic Cancers Undergoing Stem Cell Transplantation
[Protocol 12-016]
Giralt, Sergio
  • Blood and Marrow Transplantation
    • Transplantation
  • Hematology
    • Multiple Myeloma
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
    • Chronic Lymphocytic Leukemia
    • Chronic Myelocytic Leukemia
    • Myelodysplastic Syndrome
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
A Phase II Study of Brentuximab (SGN-35) Given Before and After Adriamycin, Vinblastine, and Dacarbazine Therapy in Older Adults with Untreated Hodgkin Lymphoma
[Protocol 11-201]
Hamlin, Paul
  • Lymphoma
    • Hodgkin's Disease
A Phase II Study of Bortezomib/Dexamethasone Followed by Lenalidomide in Nonresponders as Initial Treatment for Multiple Myeloma
[Protocol 13-064]
Hassoun, Hani
  • Hematology
    • Multiple Myeloma
A Phase II Study of BKM120 in Metastatic Transitional Cell Carcinoma of the Urothelium
[Protocol 11-060]
Bajorin, Dean
  • Bladder Cancer
A Phase II Study of Bevacizumab, Irinotecan, and Temozolomide for Relapsed or Refractory Neuroblastoma
[Protocol 10-015]
Modak, Shakeel
  • Neuroblastoma
A Phase II Study of Bendamustine and Dexamethasone in Patients with Relapsed Amyloidosis
[Protocol 12-257]
Landau, Heather
  • Hematology
    • Hematologic Disorders
    • Hematologic Malignancies
A Phase II Study of Axitinib plus Dalantercept or Placebo for Patients with Metastatic Kidney Cancer
[Protocol 12-255]
Voss, Martin
  • Kidney Cancer
A Phase II Study of AMG 337 in Patients with Stomach and Esophageal Cancers with High Levels of the MET Protein
[Protocol 13-261]
Ku, Geoffrey
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
A Phase II Study of Afatinib (BIBW 2992) in Patients with Advanced HER2-Positive Esophagogastric Cancer Refractory to Trastuzumab
[Protocol 11-166]
Janjigian, Yelena
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
A Phase II Study of Abiraterone, Prednisone, and Degarelix in Men with Recurrent Prostate Cancer and a Rising PSA
[Protocol 12-187]
Scher, Howard
  • Prostate Cancer
    • Rising PSA After Primary Therapy
A Phase II Study of Abiraterone with or without Cabazitaxel in Patients with Metastatic Castration-Resistance Prostate Cancer
[Protocol 14-046]
Slovin, Susan
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase II Study of a Pediatric-Inspired Combination Chemotherapy Regimen in Adults with Acute Lymphoblastic Leukemia
[Protocol 12-266]
Douer, Dan
  • Leukemia
    • Acute Lymphoblastic Leukemia
A Phase II Study of 5'-Azacitidine to Prevent Recurrence in Patients Who Had a Donated Stem Cell Transplant for Acute Myeloid Leukemia or Myelodysplastic Syndromes
[Protocol 13-192]
Tamari, Roni
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase II Study Evaluating the Use of Donated EBV-Immune T Cells to Treat Transplant Recipients with EBV
[Protocol 11-130]
O'Reilly, Richard
  • Blood and Marrow Transplantation
    • Transplantation
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study Comparing Three Months versus Two Years of Afatinib Therapy after Surgery for Patients with Stage I-III Non-Small Cell Lung Cancer
[Protocol 13-096]
Chaft, Jamie
  • Lung Cancer, Non-Small Cell
A Phase II Study Comparing Romiplostim with Observation for Chemotherapy-Induced Thrombocytopenia
[Protocol 13-132]
Soff, Gerald
  • Hematology
    • Hematologic Disorders
  • Solid Tumors
A Phase II Study Assessing PET/CT Scanning to Guide Radiation Treatment for Inoperable Stage III Non-Small Cell Lung Cancer
[Protocol 14-032]
Gelblum, Daphna
  • Lung Cancer, Non-Small Cell